Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
UBS
Covington
Healthtrust
Express Scripts
Deloitte
McKesson
Dow
Colorcon
AstraZeneca

Generated: January 19, 2018

DrugPatentWatch Database Preview

FORADIL Drug Profile

« Back to Dashboard

When do Foradil patents expire, and what generic alternatives are available?

Foradil is a drug marketed by Novartis and is included in two NDAs. There are two patents protecting this drug.

This drug has fifty-three patent family members in twenty-seven countries.

The generic ingredient in FORADIL is formoterol fumarate. There are seventeen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the formoterol fumarate profile page.
Drug patent expirations by year for FORADIL
Pharmacology for FORADIL
Medical Subject Heading (MeSH) Categories for FORADIL

US Patents and Regulatory Information for FORADIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis FORADIL formoterol fumarate POWDER;INHALATION 020831-001 Feb 16, 2001 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis FORADIL formoterol fumarate POWDER;INHALATION 020831-001 Feb 16, 2001 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis FORADIL CERTIHALER formoterol fumarate POWDER;INHALATION 021592-001 Dec 15, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for FORADIL

Country Document Number Estimated Expiration
Poland 354974 ➤ Subscribe
Japan 3094437 ➤ Subscribe
China 1399540 ➤ Subscribe
Poland 342825 ➤ Subscribe
Brazil 9908587 ➤ Subscribe
Australia 3032399 ➤ Subscribe
Canada 2322575 ➤ Subscribe
Brazil 0015908 ➤ Subscribe
Japan 2013075909 ➤ Subscribe
Australia 769765 ➤ Subscribe
Country Document Number Estimated Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for FORADIL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
02C/022 Belgium ➤ Subscribe PRODUCT NAME: BUDESONID. MICRONIS. AND FORMOTEROL. FUMARAS DIHYDR., NATL REGISTRATION NO/DATE: 624 IS 234 F 0 20010129; FIRST REGISTRATION: SE 16047 20000825
C/GB02/033 United Kingdom ➤ Subscribe PRODUCT NAME: FORMOTEROL (OPTIONALLY IN THE FORM OF THE FREE BASE OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, OR A SOLVATE OF SUCH FREE BASE OR SALT ESPECIALLY AS FORMOTEROL FUMARATE DIHYDRATE) AND BUDESONIDE; REGISTERED: SE SE16047, 16048 20000825; UK PL17901/0091 20010515; UK PL17901/0092 20010515
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Fish and Richardson
Medtronic
Accenture
Deloitte
Boehringer Ingelheim
Chubb
Cerilliant
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot